| Dr Michael D North, OD | |
|
1982 W Grand River Ave, Suite 815, Okemos, MI 48864-1736 | |
| (517) 349-0784 | |
| Not Available |
| Full Name | Dr Michael D North |
|---|---|
| Gender | Male |
| Speciality | Optometrist |
| Location | 1982 W Grand River Ave, Okemos, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639215429 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 4901002944 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael D North, OD 13468 Cottage View Ct, Gowen, MI 49326-9496 Ph: (616) 200-5131 | Dr Michael D North, OD 1982 W Grand River Ave, Suite 815, Okemos, MI 48864-1736 Ph: (517) 349-0784 |
News Archive
On January 14th 2020, City's School of Mathematics, Computer Science and Engineering (SMCSE) hosted its first National Symposium on Developing Socially Responsible STEM Professionals.
A qualitative study led by researchers at the Johns Hopkins Bloomberg School of Public Health yielded nine patient-driven recommendations across circumstances that include changes to insurance, supportive services and financial assistance to reduce long-term, breast cancer-related economic burden.
Researchers at the University of Pittsburgh have been awarded funding for two projects that will place brain-computer interfaces (BCI) in patients with spinal cord injuries to test if it is possible for them to control external devices, such as a computer cursor or a prosthetic limb, with their thoughts.
Viral conjunctivitis is a highly contagious infection, often causing major ophthalmic epidemics. There is no approved acute treatment currently approved by the FDA for viral conjunctivitis. A safe broad-spectrum antiviral agent is needed to treat this unmet medical need.
In experiments with human cells and mice, researchers at the Johns Hopkins Kimmel Cancer Center report evidence that combining the experimental cancer medication TAK228 (also called sapanisertib) with an existing anti-cancer drug called trametinib may be more effective than either drug alone in decreasing the growth of pediatric low-grade gliomas.
› Verified 2 days ago
Deltavision Optical Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2333 Jolly Rd, Okemos, MI 48864 Phone: 517-381-2000 Fax: 517-381-2006 | |
James E. Budge, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5100 Marsh Rd Ste H, Okemos, MI 48864 Phone: 517-349-0150 Fax: 517-349-0157 | |
Dr. Terri A Wolf, D.O. Optometrist Medicare: Medicare Enrolled Practice Location: 1669 Hamilton Rd, Suite 200, Okemos, MI 48864 Phone: 517-349-4743 Fax: 517-349-0096 | |
Ellen Mary Dohr, OD Optometrist Medicare: Medicare Enrolled Practice Location: 2333 Jolly Rd, Okemos, MI 48864 Phone: 517-381-2000 Fax: 517-381-2006 | |
Diana Stewart, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2333 Jolly Rd, Okemos, MI 48864 Phone: 517-381-2000 | |
Mrs. Jennifer Mckinnon, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1982 W Grand River Ave, Okemos, MI 48864 Phone: 517-349-0784 | |
Dr. Natasha Nacole Potts, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5110 Times Square Pl, Okemos, MI 48864 Phone: 517-381-8314 Fax: 517-381-8328 |